Exact Mass: 534.1373346
Exact Mass Matches: 534.1373346
Found 312 metabolites which its exact mass value is equals to given mass value 534.1373346
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
CERCOSPORIN
An organic heterohexacyclic compound that is perylo[1,12-def][1,3]dioxepine-6,11-dione substituted by hydroxy groups at positions 5 and 12, by methoxy groups at positions 7 and 10, and by 2-hydroxypropyl groups at positions 8 and 9 (the R,R-stereoisomer). It is a phytotoxin which was first isolated from the pathogenic soybean fungus, Cercospora kikuchii and later found in multiple members of the genus Cercospora. CONFIDENCE isolated standard
Luteolin 7-malonylglucoside
Luteolin 7-malonylglucoside, also known as luteolin 7-O-B-D-(6-O-malonyl) glucopyranoside, is a member of the class of compounds known as flavonoid-7-o-glycosides. Flavonoid-7-o-glycosides are phenolic compounds containing a flavonoid moiety which is O-glycosidically linked to carbohydrate moiety at the C7-position. Luteolin 7-malonylglucoside is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Luteolin 7-malonylglucoside can be found in celery leaves, globe artichoke, and wild celery, which makes luteolin 7-malonylglucoside a potential biomarker for the consumption of these food products.
Dalpanin
Aprepitant
Aprepitant, an antiemetic, is a substance P/neurokinin 1 (NK1) receptor antagonist which, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy. Aprepitant is a selective high-affinity antagonist of human substance P/neurokinin 1 (NK1) receptors. Aprepitant has little or no affinity for serotonin (5-HT3), dopamine, and corticosteroid receptors, the targets of existing therapies for chemotherapy-induced nausea and vomiting (CI NV). A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Aprepitant (MK-0869) is a selective and high-affinity neurokinin 1 receptor antagonist with a Kd of 86 pM.
4',5-Dihydroxy-3,3'-dimethoxy-6,7-methylenedioxyflavone 4'-glucuronide
4,5-Dihydroxy-3,3-dimethoxy-6,7-methylenedioxyflavone 4-glucuronide is found in green vegetables. 4,5-Dihydroxy-3,3-dimethoxy-6,7-methylenedioxyflavone 4-glucuronide is isolated from spinach (Spinacia oleracea). Isolated from spinach (Spinacia oleracea). 4,5-Dihydroxy-3,3-dimethoxy-6,7-methylenedioxyflavone 4-glucuronide is found in green vegetables and spinach.
2'-Hydroxygenistein 7-(6'-malonylglucoside)
2-Hydroxygenistein 7-(6-malonylglucoside) is found in pulses. 2-Hydroxygenistein 7-(6-malonylglucoside) is isolated from the roots of Lupinius albus (white lupin). Isolated from the roots of Lupinius albus (white lupin). 2-Hydroxygenistein 7-(6-malonylglucoside) is found in pulses and white lupine.
3,5-Dihydroxy-3',4'-dimethoxy-6,7-methylenedioxyflavone 3-glucuronide
3,5-Dihydroxy-3,4-dimethoxy-6,7-methylenedioxyflavone 3-glucuronide is found in green vegetables. 3,5-Dihydroxy-3,4-dimethoxy-6,7-methylenedioxyflavone 3-glucuronide is a constituent of spinach.
6'-Malonylastragalin
6-Malonylastragalin is found in pear. 6-Malonylastragalin is a constituent of Cicer sp. and pears. Constituent of Cicer species and pears. 6-Malonylastragalin is found in pomes, pulses, and pear.
Ceftobiprole
Delamanid
ent-Aprepitant
Rocepafant
C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors
Ruberythric acid
Sulfosuccinimidyl 6-(biotinamido)hexanoate
C20H30N4O9S2 (534.1454130000001)
Kaempferol 3-O-(6-malonyl-glucoside)
Kaempferol 3-o-(6"-malonyl-glucoside) is a member of the class of compounds known as flavonoid-3-o-glycosides. Flavonoid-3-o-glycosides are phenolic compounds containing a flavonoid moiety which is O-glycosidically linked to carbohydrate moiety at the C3-position. Kaempferol 3-o-(6"-malonyl-glucoside) is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Kaempferol 3-o-(6"-malonyl-glucoside) can be found in endive and lettuce, which makes kaempferol 3-o-(6"-malonyl-glucoside) a potential biomarker for the consumption of these food products.
Apigenin 7-(6'-malonylglucoside)
Apigenin 7-(6-malonylglucoside) is a member of the class of compounds known as flavonoid-7-o-glycosides. Flavonoid-7-o-glycosides are phenolic compounds containing a flavonoid moiety which is O-glycosidically linked to carbohydrate moiety at the C7-position. Apigenin 7-(6-malonylglucoside) is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Apigenin 7-(6-malonylglucoside) can be found in german camomile, lupine, and parsley, which makes apigenin 7-(6-malonylglucoside) a potential biomarker for the consumption of these food products.
5,4'-Dihydroxy-3,3'-dimethoxy-6,7-methylenedioxyflavone 4'-glucuronide
5,4-dihydroxy-3,3-dimethoxy-6,7-methylenedioxyflavone 4-glucuronide is a member of the class of compounds known as flavonoid o-glucuronides. Flavonoid o-glucuronides are phenolic compounds containing a flavonoid moiety which is O-glycosidically linked to glucuronic acid. 5,4-dihydroxy-3,3-dimethoxy-6,7-methylenedioxyflavone 4-glucuronide is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 5,4-dihydroxy-3,3-dimethoxy-6,7-methylenedioxyflavone 4-glucuronide can be found in spinach, which makes 5,4-dihydroxy-3,3-dimethoxy-6,7-methylenedioxyflavone 4-glucuronide a potential biomarker for the consumption of this food product.
6,8-Di-C-beta-D-arabinopyranosylapigenin
6,8-di-c-beta-d-arabinopyranosylapigenin is a member of the class of compounds known as flavonoid 8-c-glycosides. Flavonoid 8-c-glycosides are compounds containing a carbohydrate moiety which is C-glycosidically linked to 8-position of a 2-phenylchromen-4-one flavonoid backbone. 6,8-di-c-beta-d-arabinopyranosylapigenin is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). 6,8-di-c-beta-d-arabinopyranosylapigenin can be found in tea, which makes 6,8-di-c-beta-d-arabinopyranosylapigenin a potential biomarker for the consumption of this food product.
Luteolin 7-(6'-malonylglucoside)
Luteolin 7-(6-malonylglucoside) is a member of the class of compounds known as flavonoid-7-o-glycosides. Flavonoid-7-o-glycosides are phenolic compounds containing a flavonoid moiety which is O-glycosidically linked to carbohydrate moiety at the C7-position. Luteolin 7-(6-malonylglucoside) is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Luteolin 7-(6-malonylglucoside) can be found in carrot and wild carrot, which makes luteolin 7-(6-malonylglucoside) a potential biomarker for the consumption of these food products.
Apigenin 6-C-α-L-arabinopyranosyl-8-C-β-D-xylopyranoside
Apigenin 6-C-alpha-L-arabinopyranosyl-8-C-beta-D-xylopyranoside is a natural product found in Viola philippica with data available.
5,7,4-Trihydroxyflavone 6-C-xylopyranoside-8-C-arabinopyranoside
3,5,7,3,4-Pentahydroxy-6-prenylflavanone 7-glucoside
Phellatin
5,4-Dihydroxy-3,3-dimethoxy-6,7-methylenedioxyflavone 4-glucuronide
Parthenosin
Quercetin 3-(4-malonylrhamnoside)
Amurensin
Okanin 4-O-(4,6-di-O-acetylglucoside)
6,9-Dihydroxy-2,310-trimethoxy-6a,12a-didehydrorotenone 9-O-glucoside
6-C-alpha-L-Arabinopyranosyl-8-C-beta-L-arabinopyranosylapigenin
6-O-beta-L-Arabinopyranosyl-8-C-alpha-L-arabinopyranosylapigenin
5,7-Dihydroxy-6-C-methylflavanone 7-xylosyl- (1->3) -xyloside
6-Malonylastragalin
epiphyllic acid-7-O-beta-glucoside-10-methyl ester
3t-[6-(tetra-O-acetyl-beta-D-glucopyranosyloxy)-benzofuran-5-yl]-acrylic acid|3t-[6-(Tetra-O-acetyl-beta-D-glucopyranosyloxy)-benzofuran-5-yl]-acrylsaeure|psoralic acid-(6<--1)-O-beta-D-glucopyranoside acetate
apigenin-7-O-beta-D-apiofuranosyl-(1->2)-beta-D-apiofuranoside
6-beta-C-(2-galloylglucopyranosyl)-5,7-dihydroxy-2-isopropylchromone|6-beta-C-(2-O-galloylglucopyranosyl)-5,7-dihydroxy-2-isopropylchromone|6-??-C-(2-Galloylglucopyranosyl)-5,7-dihydroxy-2-isopropylchromone
1-O-[(E)-3,4-dihydroxy-5-methoxycinnamoyl]gentiobiose
5,7-Dihydroxy-6-C-methylflavanone 7-xylosyl-(1->3)-xyloside
8-beta-C-(2-galloylglucopyranosyl)-5,7-dihydroxy-2-isopropylchromone|8-beta-C-(2-O-galloylglucopyranosyl)-5,7-dihydroxy-2-isopropylchromone|8-??-C-(2-Galloylglucopyranosyl)-5,7-dihydroxy-2-isopropylchromone
4,5-di-O-(4-hydroxy-3,5-methoxy-benzoyl)-shikimic acid
7-hydroxy-3,5,8-trimethoxy-3,4-(methylenedioxy)flavone-7-O-beta-glucopyranoside
luteolin 7-O-<2-O-beta-glucopyranuronosoyl-lactate>
7-hydroxy-5,6,8-trimethoxy-3,4-(methylenedioxy)flavone-7-O-beta-glucopyranoside
2,3-dihydro-2-(4-hydroxy-3-methoxyphenyl)-3-hydroxymethyl-7-methoxybenzofuran-5-propenoic acid 4-O-beta-D-glucopyranoside|aegineoside
2,5-dihydroxy-4-methoxyphenanthrene 2-O-beta-D-apiofuranosyl-(1-6)-beta-D-glucopyranoside|denneanoside E
(5aS)-5c,13c-diacetoxy-7a,15a-bis-methylsulfanyl-(5ar,7at,13ac,15at)-5,5a,7a,8,13,13a,15a,16-octahydro-bis(oxepino[3,4:4,5]pyrrolo)[1,2-a;1,2-d]pyrazine-7,15-dione|bisdethiobis(methylthio)acetylaranotin|bisdethiodi(methylthio)acetylaranotin|Didethiodi(methylthio)acetylaranotin|O-acetyl-S,S-dimethyl-S,S-dihydro-aranotin|S,S-Seco-S,S-dimethyl-acetylaranotin
C24H26N2O8S2 (534.1130516000001)
4-O-(beta-D-Arabinopyranosl-beta-D-galactopyranoside)- 3,4-Dihydroxychalcone
6-O-p-coumaroylgeniposide|6-O-trans-p-coumaroylgeniposide
Hexa-Ac-beta-Pyranose-4-O-alpha-D-Xylopyranosyl-D-xylose|Hexa-Ac-beta-Pyranose-Xylobiose
5,3,4-trihydroxy-3-methoxy-6:7-methylenedioxyflavone 4-beta-D-glucuronide methyl ester
2, 4, 5, 7, 8, 9-Hexa-Ac, Me ester-3-Deoxy-D-glycero-D-galacto-2-nonulosonic acid, 9CI
isopsoralic acid-(4<--1)-O-beta-D-glucopyranoside acetate
6-C-beta-D-xylopyranosyl-8-C-alpha-L-arabinopyranosylapigenin
3,4-Dihydroxychalcone 4-beta-L-arabinopyranosyl-(1->4)-galactoside
Apigenin-6-C-β-D-xylopyranosyl-8-C-α-L-arabinopyranoside
Apigenin6-C-α-L-arabinopyranosyl-8-C-β-D-xylopyranoside
Apigenin 6-C-alpha-L-arabinopyranosyl-8-C-beta-D-xylopyranoside is a natural product found in Viola philippica with data available.
Aprepitant
A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Aprepitant (MK-0869) is a selective and high-affinity neurokinin 1 receptor antagonist with a Kd of 86 pM.
Conivaptan HCl
C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2180 - Vasopressin Antagonist D045283 - Natriuretic Agents > D065092 - Antidiuretic Hormone Receptor Antagonists D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents
5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis(3,4,5-trihydroxyoxan-2-yl)chromen-4-one
5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis(3,4,5-trihydroxyoxan-2-yl)chromen-4-one
3-[4-hydroxy-5-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2-(2-oxochromen-7-yl)oxypropanoic acid
C26H30O12_Cyclopenta[c]pyran-4-carboxylic acid, 1,4a,5,7a-tetrahydro-7-(hydroxymethyl)-1-[[6-O-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]-beta-D-glucopyranosyl]oxy]-, methyl ester
C22H27ClO13_(1R,4S,5R,6S,7R,8S)-5-Chloro-9-(beta-D-glucopyranosyloxy)-4-hydroxy-2,10-dioxatricyclo[5.3.1.0~4,8~]undec-6-yl 3,4-dihydroxybenzoate
5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis(3,4,5-trihydroxyoxan-2-yl)chromen-4-one [IIN-based: Match]
5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis(3,4,5-trihydroxyoxan-2-yl)chromen-4-one [IIN-based on: CCMSLIB00000846878]
3-[4-hydroxy-5-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2-(2-oxochromen-7-yl)oxypropanoic acid [IIN-based: Match]
3-[4-hydroxy-5-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2-(2-oxochromen-7-yl)oxypropanoic acid [IIN-based on: CCMSLIB00000848198]
Cys Cys Phe Tyr
Cys Cys Tyr Phe
Cys Phe Cys Tyr
Cys Phe Tyr Cys
Cys Ser Tyr Tyr
Cys Tyr Cys Phe
Cys Tyr Phe Cys
Cys Tyr Ser Tyr
Cys Tyr Tyr Ser
Glu Glu Glu Glu
Phe Cys Cys Tyr
Phe Cys Tyr Cys
Phe Tyr Cys Cys
Ser Cys Tyr Tyr
Ser Tyr Cys Tyr
Ser Tyr Tyr Cys
Tyr Cys Cys Phe
Tyr Cys Phe Cys
Tyr Cys Ser Tyr
Tyr Cys Tyr Ser
Tyr Phe Cys Cys
Tyr Ser Cys Tyr
Tyr Ser Tyr Cys
Tyr Tyr Cys Ser
Tyr Tyr Ser Cys
6''-Malonylastragalin
4',5-Dihydroxy-3,3'-dimethoxy-6,7-methylenedioxyflavone 4'-glucuronide
3,5-Dihydroxy-3',4'-dimethoxy-6,7-methylenedioxyflavone 3-glucuronide
2'-Hydroxygenistein 7-(6''-malonylglucoside)
5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis(3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)-4H-chromen-4-one
Delamanid
J - Antiinfectives for systemic use > J04 - Antimycobacterials > J04A - Drugs for treatment of tuberculosis C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent
2-(biphenyl-4-yl)-4,6-diphenylpyrylium perchlorate
sulphosuccinimidyl-6-(biotinamido)hexanoate
C20H30N4O9S2 (534.1454130000001)
Bis(cyclopenta-1,3-diene)bis(1-(2,4-difluorophenyl)-3H-pyrrol-3-yl)titanium
C30H22F4N2Ti (534.1198489999999)
Trisiloxane, 3,3-(1,2-ethanediyl)bis[3-[(diMethylsilyl)oxy]-1,1,5,5-tetraMethyl-
Phenylmethyl 4-O-(3-O-sulfo-beta-D-galactopyranosyl)-beta-D-glucopyranoside monosodium salt
Ceftobiprole
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Praliciguat
C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D005765 - Gastrointestinal Agents > D000074268 - Guanylyl Cyclase C Agonists D020536 - Enzyme Activators
3,3-Dimethoxy-4-(beta-D-glucopyranuronosyloxy)-5-hydroxy-6,7-(methylenedioxy)flavone
1-Benzyl-1-[[3-(4-chlorophenyl)-5-methyl-1-benzofuran-2-yl]methyl]-3-(2,4,6-trifluorophenyl)urea
5-[[(2S,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-1,2,4-triazol-3-one
(R)-lipoyl-AMP(1-)
A lipoyl-AMP(1-) obtained by deprotonation of the phosphate OH group of (R)-lipoyl-AMP; major species at pH 7.3.
(6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-oxidoiminoacetyl]amino]-8-oxo-3-[(E)-[2-oxo-1-[(3R)-pyrrolidin-1-ium-3-yl]pyrrolidin-3-ylidene]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
3-[[(2R,3S,4S,5R,6S)-6-[2-(3,4-dihydroxyphenyl)-5-hydroxy-7-oxochromen-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-3-oxopropanoic acid
7-[[(2E)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-hydroxyiminoacetyl]amino]-8-oxo-3-[(Z)-(2-oxo-1-pyrrolidin-3-ylpyrrolidin-3-ylidene)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
4-[3,5-Bis(benzyloxy)phenyl]-6-(5-chloro-2-hydroxyphenyl)-2-oxo-1,2-dihydropyridine-3-carbonitrile
1-[4-[(5-bromo-2-pyridinyl)-[(4-chlorophenyl)methyl]amino]butyl]-3-[3-(1H-imidazol-5-yl)propyl]thiourea
lipoyl-AMP(1-)
Conjugate base of lipoyl-AMP arising from deprotonation of the free phosphate OH group.
2-(Thiophen-2-ylsulfonylamino)benzoic acid [2-(3-acetylanilino)-2-oxo-1-phenylethyl] ester
3-(1,3-benzodioxol-5-yl)-1-[[(2R,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methylurea
Ethyl 2-[4-[(7-chloro-4-quinolyl)amino]butylamino]-4-methyl-6-(2-nitrophenyl)pyrimidine-5-carboxylate
N-[(1R,3R,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
6-C-alpha-L-arabinosyl-8-C-beta-L-arabinosylapigenin
N-[(1R,3R,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3R,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3S,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3R,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3S,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3S,4aR,9aS)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3S,4aS,9aR)-3-[2-[(3-fluorophenyl)methylamino]-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
ustilaginoidin I
A binaphthopyran resulting from the formal oxidative coupling at positions 9 of molecules of 5,6,8-trihydroxy-2-(hydroxymethyl)-2,3-dihydro-4H-benzo[g]chromen-4-one and (6S)-5,6,8-trihydroxy-2-methyl-6,9-dihydro-4H-benzo[g]chromen-4-one.
6-[2-[2-(2,4-Dihydroxyphenyl)-2-oxoethyl]-5-hydroxy-3-methoxy-4-(3-methylbut-2-enyl)phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
6-[(8,11-Dihydroxy-17-methoxy-10-oxo-2-oxatricyclo[13.2.2.13,7]icosa-1(17),3,5,7(20),15,18-hexaen-4-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2R,3R,4R,5R)-3,4,5-trihydroxyoxan-2-yl]-8-[(2R,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one
6-[4-[2-(2,4-Dihydroxyphenyl)-2-oxoethyl]-5-hydroxy-3-methoxy-2-(3-methylbut-2-enyl)phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2R,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]-8-[(2R,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one
5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(2S,3R,4R,5S)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one
3-[4-hydroxy-5-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2-(2-oxochromen-7-yl)oxypropanoic acid
3,5-Dihydroxy-3,4-dimethoxy-6,7-methylenedioxyflavone 3-glucuronide
4,5-Dihydroxy-3,3-dimethoxy-6,7-methylenedioxyflavone 4-glucuronide
6-C-(alpha-L-arabinosyl)-8-C-(beta-L-arabinosyl)apigenin
A flavone C-glycoside that consists of apigenin carrying alpha-L-arabinosyl and beta-L-arabinosyl groups at positions 6 and 8 respectively
BMS-986188
BMS-986188 is a selective positive allosteric modulator of δ-opioid receptor with an EC50 of 0.05 μM[1].
UPGL00004
UPGL00004 is a potent allosteric glutaminase C (GAC) inhibitor (IC50=29 nM; Kd=27 nM). UPGL00004 strongly inhibits the proliferation of highly aggressive triple-negative breast cancer cell lines[1].
{3,4,5-trihydroxy-6-[3-(3-oxo-1h-2-benzofuran-1-yl)propoxy]oxan-2-yl}methyl 2-hydroxy-2-(4-hydroxy-3-methoxyphenyl)acetate
5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]-8-[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one
2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxochromen-7-yl 2-(3,4,5,6-tetrahydroxyoxane-2-carbonyloxy)propanoate
5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one
2-(benzoyloxy)-4',5,6-trihydroxy-4-(4-hydroxyphenyl)-[1,1'-biphenyl]-3-yl benzoate
3-(6-{[3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]oxy}-1-benzofuran-5-yl)prop-2-enoic acid
[(9s)-4,5,9-trihydroxy-10-oxo-9-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]anthracen-2-yl]methyl (2r,3s)-3-hydroxy-2-methylbutanoate
(2r)-2-amino-4-{4-[(e)-{[(3s)-1-[carboxy(3-chloro-4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]-c-hydroxycarbonimidoyl}(hydroxyimino)methyl]phenoxy}butanoic acid
2-(1-{[5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl]oxy}hexyl)-1,3,6,8-tetrahydroxyanthracene-9,10-dione
methyl (2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(2-hydroxy-4-{9-hydroxy-7-methoxy-8-oxo-2h-[1,3]dioxolo[4,5-g]chromen-6-yl}phenoxy)oxane-2-carboxylate
9,17-dihydroxy-5,21-bis(2-hydroxypropyl)-6,20-dimethoxy-12,14-dioxahexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1(15),2,4(22),5,8,10,16,18(23),20-nonaene-7,19-dione
5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2r,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]-6-[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one
2-(5,7-dihydroxy-2-isopropyl-4-oxochromen-6-yl)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3,4,5-trihydroxybenzoate
7,19-dihydroxy-5,21-bis[(2s)-2-hydroxypropyl]-6,20-dimethoxy-12,14-dioxahexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1,3(8),4,6,10,15,18(23),19,21-nonaene-9,17-dione
16-(acetyloxy)-1,12-bis(methylsulfanyl)-2,13-dioxo-8,19-dioxa-3,14-diazapentacyclo[12.8.0.0³,¹².0⁴,¹⁰.0¹⁵,²¹]docosa-6,9,17,20-tetraen-5-yl acetate
C24H26N2O8S2 (534.1130516000001)
3-(4-{[3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]oxy}-1-benzofuran-5-yl)prop-2-enoic acid
6-c-β-l-arabinopyranosyl-8-c-α-l-arabinopyra-nosylapigenin
{"Ingredient_id": "HBIN012288","Ingredient_name": "6-c-\u03b2-l-arabinopyranosyl-8-c-\u03b1-l-arabinopyra-nosylapigenin","Alias": "NA","Ingredient_formula": "C25H26O13","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1560","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-γ,γ-dimethylallyltaxifolin 7-o-β-d-glucoside
{"Ingredient_id": "HBIN012842","Ingredient_name": "6-\u03b3,\u03b3-dimethylallyltaxifolin 7-o-\u03b2-d-glucoside","Alias": "NA","Ingredient_formula": "C26H30O12","Ingredient_Smile": "CC(=CCC1=C(C=C2C(=C1O)C(=O)C(C(O2)C3=CC(=C(C=C3)O)O)O)OC4C(C(C(C(O4)CO)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6310","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
apigenin-6-c-α-l-arabinopyranosyl-8-c-β-d-xylopyranoside
{"Ingredient_id": "HBIN016423","Ingredient_name": "apigenin-6-c-\u03b1-l-arabinopyranosyl-8-c-\u03b2-d-xylopyranoside","Alias": "NA","Ingredient_formula": "C25H26O13","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14329","TCMID_id": "1481","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
apigenin-6-c-α-l-arabinopyranosyl-8-c-β-l-arabinopyranoside
{"Ingredient_id": "HBIN016424","Ingredient_name": "apigenin-6-c-\u03b1-l-arabinopyranosyl-8-c-\u03b2-l-arabinopyranoside","Alias": "NA","Ingredient_formula": "C25H26O13","Ingredient_Smile": "C1C(C(C(C(O1)C2=C(C3=C(C(=C2O)C4C(C(C(CO4)O)O)O)OC(=CC3=O)C5=CC=C(C=C5)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14328","TCMID_id": "1480","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
apigenin-6-c-β-d-xylopyranosyl-8-c-α-l-arabi-nopyranoside
{"Ingredient_id": "HBIN016429","Ingredient_name": "apigenin-6-c-\u03b2-d-xylopyranosyl-8-c-\u03b1-l-arabi-nopyranoside","Alias": "NA","Ingredient_formula": "C25H26O13","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14337","TCMID_id": "1501","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-hydroxy-3-[(3,4,5-trihydroxy-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxan-2-yl)oxy]anthracene-9,10-dione
[3-(acetyloxy)-6-{4-[3-(3,4-dihydroxyphenyl)prop-2-enoyl]-2,3-dihydroxyphenoxy}-4,5-dihydroxyoxan-2-yl]methyl acetate
(2s,3r,4s,5s,6r)-2-(5,7-dihydroxy-2-isopropyl-4-oxochromen-8-yl)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3,4,5-trihydroxybenzoate
methyl (2s,3r,4r,5s,6r)-6-(2h-1,3-benzodioxol-5-yl)-3-(formyloxy)-2-hydroxy-10,12-dimethoxy-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboxylate
3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl 3-(3,4-dihydroxy-5-methoxyphenyl)prop-2-enoate
5,7-dihydroxy-2-(4-hydroxyphenyl)-6,8-bis[(2r,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one
[(2s,3s,4r,5r,6s)-3-(acetyloxy)-6-{4-[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]-2,3-dihydroxyphenoxy}-4,5-dihydroxyoxan-2-yl]methyl acetate
(2r,3r,4s,5s)-2,4-bis({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-3,5-dihydroxyhexanedioic acid
methyl 6-(2h-1,3-benzodioxol-5-yl)-3-(formyloxy)-2-hydroxy-10,12-dimethoxy-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboxylate
2,5-bis({[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-3,4-dihydroxyhexanedioic acid
5-(furan-3-yl)-3,11-dimethyl-12-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6,14,16-trioxapentacyclo[10.3.2.0²,¹¹.0³,⁸.0¹³,¹⁵]heptadec-8-ene-7,17-dione
6-chloro-7-hydroxy-7-(hydroxymethyl)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-5-yl 3,4-dihydroxybenzoate
6-[(2s,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-8-[(2s,3r,4r,5s)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one
10-chloro-2,4-dihydroxy-7-(4-hydroxy-2-methoxy-6-methylphenyl)-9-methoxy-12,12-dimethyltetracene-5,6,11-trione
(1s,2s,3s,5r,11r,12s,13s,15s)-5-(furan-3-yl)-3,11-dimethyl-12-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6,14,16-trioxapentacyclo[10.3.2.0²,¹¹.0³,⁸.0¹³,¹⁵]heptadec-8-ene-7,17-dione
7-[(3-{[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-4-hydroxy-4-(hydroxymethyl)oxolan-2-yl)oxy]-5-hydroxy-2-(4-hydroxyphenyl)chromen-4-one
(1s,4as,7r,7as)-4'-[(r)-hydroxy(4-hydroxyphenyl)methyl]-5'-oxo-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4a,7a-dihydro-1h-spiro[cyclopenta[c]pyran-7,2'-furan]-4-carboxylic acid
5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2r,3r,4r,5r)-3,4,5-trihydroxyoxan-2-yl]-6-[(2r,3s,4s,5r)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one
(2s,3r,4s,5s,6r)-2-(5,7-dihydroxy-2-isopropyl-4-oxochromen-6-yl)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3,4,5-trihydroxybenzoate
(2r,3s,4r,5s)-2,5-bis({[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-3,4-dihydroxyhexanedioic acid
7,19-dihydroxy-5,21-bis(2-hydroxypropyl)-6,20-dimethoxy-12,14-dioxahexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1,3(8),4,6,10,15,18(23),19,21-nonaene-9,17-dione
(1r,4as,7r,7as)-4'-[hydroxy(4-hydroxyphenyl)methyl]-5'-oxo-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4a,7a-dihydro-1h-spiro[cyclopenta[c]pyran-7,2'-furan]-4-carboxylic acid
5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2r,3r,4r,5s)-3,4,5-trihydroxyoxan-2-yl]-8-[(2s,3r,4r,5s)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one
6,8-bis[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one
4'-[hydroxy(4-hydroxyphenyl)methyl]-5'-oxo-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4a,7a-dihydro-1h-spiro[cyclopenta[c]pyran-7,2'-furan]-4-carboxylic acid
3-{[(2s,3r,4s,5s,6s)-6-{[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy}-4,5-dihydroxy-2-methyloxan-3-yl]oxy}-3-oxopropanoic acid
(1r,4r,5r,12r,15s,16r)-16-(acetyloxy)-1,12-bis(methylsulfanyl)-2,13-dioxo-8,19-dioxa-3,14-diazapentacyclo[12.8.0.0³,¹².0⁴,¹⁰.0¹⁵,²¹]docosa-6,9,17,20-tetraen-5-yl acetate
C24H26N2O8S2 (534.1130516000001)
3-{[(2s,3r,4r,5s)-5-[(1r)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy}-1,6,8-trihydroxy-2-[(1s)-1-hydroxyhexyl]anthracene-9,10-dione
(2e)-3-(4-{[(2s,3r,4s,5r,6r)-3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]oxy}-1-benzofuran-5-yl)prop-2-enoic acid
3-[(6-{[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy}-4,5-dihydroxy-2-methyloxan-3-yl)oxy]-3-oxopropanoic acid
3,5-dihydroxy-8-(3-hydroxy-3-methylbutyl)-2-(4-hydroxyphenyl)-7-{[(2s,3r,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-({14-hydroxy-7,13-dimethoxy-3,10-dioxo-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4,6,8(16),11(15),12-hexaen-6-yl}oxy)oxan-2-yl]methyl acetate
methyl 3,4,5-trihydroxy-6-(2-hydroxy-4-{9-hydroxy-7-methoxy-8-oxo-2h-[1,3]dioxolo[4,5-g]chromen-6-yl}phenoxy)oxane-2-carboxylate
5,7-dihydroxy-2-(4-hydroxyphenyl)-6-[(2r,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]-8-[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one
[(2s,3r,4r,5s,6s)-3,4,5-trihydroxy-6-{3-[(1s)-3-oxo-1h-2-benzofuran-1-yl]propoxy}oxan-2-yl]methyl (2r)-2-hydroxy-2-(4-hydroxy-3-methoxyphenyl)acetate
5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]-6-[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl (2e)-3-(3,4-dihydroxy-5-methoxyphenyl)prop-2-enoate
[4-(acetyloxy)-6-{4-[3-(3,4-dihydroxyphenyl)prop-2-enoyl]-2,3-dihydroxyphenoxy}-3,5-dihydroxyoxan-2-yl]methyl acetate
3-{[(2s,3r,4s,5r,6s)-6-{[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy}-4,5-dihydroxy-2-methyloxan-3-yl]oxy}-3-oxopropanoic acid
(1r,2s,3s,5r,11r,12r,13s,15s)-5-(furan-3-yl)-3,11-dimethyl-12-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6,14,16-trioxapentacyclo[10.3.2.0²,¹¹.0³,⁸.0¹³,¹⁵]heptadec-8-ene-7,17-dione
(2r)-2-amino-4-{4-[(e)-{[(3s)-1-[(r)-carboxy(3-chloro-4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl]-c-hydroxycarbonimidoyl}(hydroxyimino)methyl]phenoxy}butanoic acid
3-{[(2r,3s,4s,5r,6s)-6-{[2-(3,4-dihydroxyphenyl)-7-hydroxy-4-oxochromen-5-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methoxy}-3-oxopropanoic acid
(2e)-3-(6-{[(2s,3r,4s,5r,6r)-3,4,5-tris(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]oxy}-1-benzofuran-5-yl)prop-2-enoic acid
7-(3-chloro-4-hydroxy-2-methoxy-6-methylphenyl)-2,4-dihydroxy-9-methoxy-12,12-dimethyltetracene-5,6,11-trione
(3r,4r,5s,6s)-6-[(1-{[2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxochromen-7-yl]oxy}-1-oxopropan-2-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
7,21,25-trihydroxy-9,19,31-trimethyl-2,30-dioxaoctacyclo[16.11.2.0¹,¹⁷.0³,¹⁶.0⁴,¹³.0⁶,¹¹.0¹⁷,²².0²⁴,²⁹]hentriaconta-3(16),4(13),6,8,10,14,19,21,24,26,28-undecaene-5,12,23-trione
(3r,4s,5r)-5-hydroxy-3,4-bis(4-hydroxy-3,5-dimethoxybenzoyloxy)cyclohex-1-ene-1-carboxylic acid
3-{[5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-yl]oxy}-1,6,8-trihydroxy-2-(1-hydroxyhexyl)anthracene-9,10-dione
7,19-dihydroxy-5,21-bis[(2r)-2-hydroxypropyl]-6,20-dimethoxy-12,14-dioxahexacyclo[13.8.0.0²,¹¹.0³,⁸.0⁴,²².0¹⁸,²³]tricosa-1,3(8),4,6,10,15,18(23),19,21-nonaene-9,17-dione
{4,5,9-trihydroxy-10-oxo-9-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]anthracen-2-yl}methyl 3-hydroxy-2-methylbutanoate
2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxochromen-7-yl (2r)-2-[(2s,3s,4s,5r,6r)-3,4,5,6-tetrahydroxyoxane-2-carbonyloxy]propanoate
2-amino-4-{4-[({1-[carboxy(3-chloro-4-hydroxyphenyl)methyl]-2-oxoazetidin-3-yl}-c-hydroxycarbonimidoyl)(hydroxyimino)methyl]phenoxy}butanoic acid
7-(3-chloro-2,4-dimethoxy-6-methylphenyl)-2,4,9-trihydroxy-12,12-dimethyltetracene-5,6,11-trione
5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2r,3r,4r,5s)-3,4,5-trihydroxyoxan-2-yl]-6-[(2s,3s,4s,5s)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one
2-[(1s)-1-{[(2r,3r,4r,5s)-5-[(1r)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy}hexyl]-1,3,6,8-tetrahydroxyanthracene-9,10-dione
(2s,3s,4s,5r,6s)-6-{[6-(3,4-dimethoxyphenyl)-9-hydroxy-8-oxo-2h-[1,3]dioxolo[4,5-g]chromen-7-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid
7-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-1-hydroxy-10h-anthracen-9-one
(2s,3r)-2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-6-(3-methylbut-2-en-1-yl)-7-{[(2s,3r,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2,3-dihydro-1-benzopyran-4-one
(2r,3r,4s,5s,6r)-2-{[(2s,3s,4s)-4-[(s)-2h-1,3-benzodioxol-5-yl(hydroxy)methyl]-2-(2h-1,3-benzodioxol-5-yl)oxolan-3-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1r,4s,5s,12r,15s,16s)-16-(acetyloxy)-1,12-bis(methylsulfanyl)-2,13-dioxo-8,19-dioxa-3,14-diazapentacyclo[12.8.0.0³,¹².0⁴,¹⁰.0¹⁵,²¹]docosa-6,9,17,20-tetraen-5-yl acetate
C24H26N2O8S2 (534.1130516000001)